AccuStem Sciences, Inc.
ACUT
$0.28
-$0.04-12.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.48M | 1.41M | 1.38M | 1.28M | 1.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.76M | 1.61M | 1.54M | 1.42M | 1.51M |
| Operating Income | -1.76M | -1.61M | -1.54M | -1.42M | -1.51M |
| Income Before Tax | -1.76M | -1.61M | -1.54M | -1.42M | -1.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.76 | -1.61 | -1.54 | -1.42 | -1.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.76M | -1.61M | -1.54M | -1.42M | -1.51M |
| EBIT | -1.76M | -1.61M | -1.54M | -1.42M | -1.51M |
| EBITDA | -1.76M | -1.61M | -1.54M | -1.42M | -1.50M |
| EPS Basic | -0.12 | -0.12 | -0.12 | -0.12 | -0.13 |
| Normalized Basic EPS | -0.07 | -0.07 | -0.08 | -0.07 | -0.08 |
| EPS Diluted | -0.12 | -0.12 | -0.12 | -0.12 | -0.13 |
| Normalized Diluted EPS | -0.07 | -0.07 | -0.08 | -0.07 | -0.08 |
| Average Basic Shares Outstanding | 60.95M | 56.57M | 51.84M | 47.12M | 45.74M |
| Average Diluted Shares Outstanding | 60.95M | 56.57M | 51.84M | 47.12M | 45.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |